Skip to main content
Log in

Case Series of Behavioral Psychotherapy for Obsessive-Compulsive Symptoms in Youth with Prader-Willi Syndrome

  • Original Article
  • Published:
Journal of Developmental and Physical Disabilities Aims and scope Submit manuscript

Abstract

Obsessive-compulsive symptoms among youth with Prader-Willi Syndrome (PWS) are frequently present and associated with considerable problems in the daily functioning of the child and his/her family. Although pharmacological and psychosocial treatments exist that target obsessive-compulsive symptoms among typically developing youth, these treatments have not been systematically adapted and/or evaluated for this population. Furthermore, although psychotropic medications have shown promising support in addressing obsessive-compulsive symptoms in several case reports involving youth with PWS, associated efficacy is modest and potential for side effects is a realistic concern. Given efficacy and tolerability of cognitive-behavioral treatment for obsessive-compulsive symptoms in typically developing youth, an adapted version of this approach may hold promise in treating clinically problematic obsessive-compulsive symptoms in youth with PWS. Thus, we report on a case series of behavioral treatment for obsessive-compulsive symptoms in three youth with PWS. Diagnostic and symptom severity assessments were conducted at screening, pre-treatment, and post-treatment by a trained independent evaluator. All youth were considered treatment responders and exhibited meaningful reductions in compulsion severity, overall obsessive-compulsive severity, and obsessive-compulsive related impairment. These data provide preliminary evidence for the utility of behavioral therapy in treating obsessive-compulsive symptoms in youth with PWS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abramowitz, J. A., Whiteside, S., & Deacon, B. (2005). The effectiveness of treatment for pediatric obsessive-compulsive disorder: a meta-analysis. Behavior Therapy, 36, 55–63.

    Article  Google Scholar 

  • Benjamin, E., & Buot-Smith, T. (1993). Naltrexone and fluoxetine in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 870–873.

    Article  PubMed  Google Scholar 

  • Clark, D. J., Boer, H., Whittington, J., Holland, A., Butler, J., & Webb, T. (2002). Prader-Willi syndrome, compulsive and ritualistic behaviors: the first population based survey. The British Journal of Psychiatry, 180, 358–362.

    Article  Google Scholar 

  • Correll, C. U., Manu, P., Olshanskiy, V., Napolitano, B., Kane, J. M., & Malhotra, A. K. (2009). Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. Journal of the American Medical Association, 302, 1765–1773.

    Article  PubMed  Google Scholar 

  • Dech, B., & Budow, L. (1991). The use of fluoxetine in an adolescent with Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 298–302.

    Article  PubMed  Google Scholar 

  • Dimitropoulos, A., Feurer, I. D., Butler, M., & Thompson, T. (2001). Emergence of compulsive behaviors and tantrums in children with Prader-Willi syndrome. American Journal of Mental Retardation, 106, 39–51.

    Article  PubMed  Google Scholar 

  • Dimitropoulos, A., Blackford, J., Walden, T., & Thompson, T. (2006). Compulsive behavior in Prader-Willi syndrome: examining severity in early childhood. Research in Developmental Disabilties, 27, 190–202.

    Article  Google Scholar 

  • Dykens, E. M., & Shah, B. (2003). Psychiatric disorders in Prader–Willi syndrome: epidemiology and management. CNS Drugs, 17, 167–178.

    Article  PubMed  Google Scholar 

  • Dykens, E. M., Leckman, J. F., & Cassidy, S. B. (1996). Obsessions and compulsions in Prader-Willi Syndrome. Journal of Child Psychology and Psychiatry, 37, 995–1002.

    Article  PubMed  Google Scholar 

  • Foa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., et al. (2005). Randomized placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. The American Journal of Psychiatry, 162, 151–161.

    Article  PubMed  Google Scholar 

  • Guy, W. (1976). Assessment manual for psychopharmacology, revised (DHEW publication ABM 76–366). US Government Printing Office: Washington D.C.

    Google Scholar 

  • Hellings, J. A., & Warnock, J. K. (1994). Self-injurious behavior and serotonin in Prader-Willi syndrome. Psychopharmacology Bulletin, 30, 245–250.

    PubMed  Google Scholar 

  • Hergüner, S., & Mukaddes, N. M. (2007). Psychosis associated with fluoxetine in Prader-Willi syndrome. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 944–945.

    Article  PubMed  Google Scholar 

  • Kaufman, J., Birmaher, B., Brent, D., Rao, U., Flynn, C., Moreci, P., et al. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version: initial reliability and validity data. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 980–988.

    Article  Google Scholar 

  • Khanna, M. S., & Kendall, P. C. (2008). Computer-assisted CBT for child anxiety: the coping Cat CD-ROM. Cognitive and Behavioural Practice, 15, 159–165.

    Article  Google Scholar 

  • Kim, J. W., Yoo, H. J., Cho, S. C., Hong, K. E. M., & Kim, B. N. (2005). Behavioral characteristics of Prader-Willi syndrome in Korea: comparison with children with mental retardation and normal controls. Journal of Child Neurology, 20, 134–138.

    Article  PubMed  Google Scholar 

  • March, S., Spence, S. H., & Donovan, C. L. (2009). The efficacy of an internet-based cognitive-behavioural therapy intervention for child anxiety disorders. Journal of Pediatric Psychology, 34, 474–487.

    Article  PubMed  Google Scholar 

  • Masi, G., Millepiedi, S., Perugi, G., Pfanner, C., Berloffa, S., Pari, C., et al. (2009). Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study. CNS Drugs, 23, 241–252.

    Article  PubMed  Google Scholar 

  • National Institute of Mental Health. (1985). CGI (Clinical Global Impression) scale-NIMH. Psychopharmacology Bulletin, 21, 839–844.

    Google Scholar 

  • Pediatric OCD Treatment Study Team. (2004). Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive compulsive disorder. Journal of the American Medical Association, 292, 1969–1976.

    Article  Google Scholar 

  • Piacentini, J., Bergman, R. L., Keller, M., & McCracken, J. T. (2003). Functional impairment in children and adolescents with obsessive-compulsive disorder. Journal of Child and Adolescent Psychopharmacology, 13S–1, S61–S69.

    Article  Google Scholar 

  • Scahill, L., Riddle, M. A., McSwiggin-Hardin, M., Ort, S. I., King, R. A., Goodman, W. K., et al. (1997). The Children’s Yale-Brown Obsessive-Compulsive Scale: reliability and validity. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 844–853.

    Article  PubMed  Google Scholar 

  • Spence, S. H., Holmes, J. M., March, S., & Lipp, O. V. (2006). The feasibility and outcome of clinic plus internet delivery of cognitive-behavior therapy for childhood anxiety. Journal of Consulting and Clinical Psychology, 74, 614–621.

    Article  PubMed  Google Scholar 

  • State, M. W., Dykens, E. M., Rosner, B., Martin, A., & King, B. H. (1999). Obsessive-compulsive symptoms in Prader-Willi and “Prader-Willi-Like” patients. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 329–334.

    Article  PubMed  Google Scholar 

  • Storch, E. A., Murphy, T. K., Geffken, G. R., Soto, O., Sajid, M., Allen, P., et al. (2004). Psychometric evaluation of the Children’s Yale-Brown Obsessive Compulsive Scale. Psychiatry Research, 129, 91–98.

    Article  PubMed  Google Scholar 

  • Storch, E. A., Geffken, G. R., Merlo, L., Mann, G., Duke, D., Munson, M., et al. (2007). Family-based cognitive-behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 469–478.

    Article  PubMed  Google Scholar 

  • Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363, 1341–1345.

    Article  PubMed  Google Scholar 

  • Wigren, M., & Hansen, S. (2003). Rituals and compulsivity in Prader-Willi syndrome: profile and stability. Journal of Intellectual Disability Research, 47, 428–438.

    Article  PubMed  Google Scholar 

  • Wigren, M., & Hansen, S. (2005). ADHD symptoms and insistence on sameness in Prader-Willi syndrome. Journal of Intellectual Disability Research, 49, 449–456.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric A. Storch.

Additional information

This study was funded by a grant to the first author from the Foundation for Prader Willi Research. The contributions of Danielle Bodzin, B.S., Daniel Driscoll, M.D., Ph.D., Amy Parks, Psy.D., and Theresa Strong, Ph.D. are noted.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Storch, E.A., Rahman, O., Morgan, J. et al. Case Series of Behavioral Psychotherapy for Obsessive-Compulsive Symptoms in Youth with Prader-Willi Syndrome. J Dev Phys Disabil 23, 359–368 (2011). https://doi.org/10.1007/s10882-011-9233-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10882-011-9233-5

Keywords

Navigation